Rite Aid (RAD) Nov. Comps Rose 0.9%

Rite Aid (NYSE: RAD) announced sales results of its retail pharmacy segment for November.

Monthly Sales

For the five weeks ended Nov. 28, 2015, same store sales increased 0.9 percent over the prior-year period. November front-end same store sales increased 1.2 percent. Pharmacy same store sales, which included an approximate 267 basis points negative impact from new generic introductions, increased 0.7 percent. Prescription count at comparable stores increased 0.8 percent over the prior-year period.

Total drugstore sales for the five-week period decreased 0.6 percent to $2.556 billion compared to $2.571 billion for the same period last year. Prescription sales accounted for 69.2 percent of drugstore sales, and third party prescription sales represented 97.9 percent of pharmacy sales.

Quarterly Sales

Same store sales for the 13-week period ended Nov. 28, 2015 increased 0.9 percent over the prior-year period. Front-end same store sales increased 0.3 percent while pharmacy same store sales increased 1.2 percent. Prescription count at comparable stores increased 0.2 percent over the prior-year period.

Total drugstore sales for the 13 weeks ended Nov. 28, 2015 increased 0.8 percent with sales of $6.701 billion compared to $6.651 billion for the same period last year. Prescription sales represented 69.9 percent of total drugstore sales, and third party prescription sales represented 97.9 percent of pharmacy sales.

Year-to-Date

Same store sales for the 39-week period ended Nov. 28, 2015 increased 1.9 percent over the prior-year period. Front-end same store sales increased 0.4 percent while pharmacy same store sales increased 2.6 percent. Prescription count at comparable stores increased 0.6 percent over the prior-year period.

Total drugstore sales for the 39 weeks ended Nov. 28, 2015 increased 1.8 percent with sales of $19.906 billion compared to $19.553 billion for the same period last year. Prescription sales represented 69.5 percent of total drugstore sales, and third party prescription sales represented 97.8 percent of pharmacy sales.

You May Also Be Interested In

• Richard Lowenthal resigns from ARS Pharmaceuticals board
• Tsmc 2q Net Income Nt$706.6b, Est. Nt$623.73b
• Braemar Hotels responds to Al Shams court filing